Add like
Add dislike
Add to saved papers

Exploration of Machine Learning for Hyperuricemia Prediction Models Based on Basic Health Checkup Tests.

BACKGROUND: Machine learning (ML) is a promising methodology for classification and prediction applications in healthcare. However, this method has not been practically established for clinical data. Hyperuricemia is a biomarker of various chronic diseases. We aimed to predict uric acid status from basic healthcare checkup test results using several ML algorithms and to evaluate the performance.

METHODS: We designed a prediction model for hyperuricemia using a comprehensive health checkup database designed by the classification of ML algorithms, such as discrimination analysis, K-nearest neighbor, naïve Bayes (NBC), support vector machine, decision tree, and random forest classification (RFC). The performance of each algorithm was evaluated and compared with the performance of a conventional logistic regression (CLR) algorithm by receiver operating characteristic curve analysis.

RESULTS: Of the 38,001 participants, 7705 were hyperuricemic. For the maximum sensitivity criterion, NBC showed the highest sensitivity (0.73), and RFC showed the second highest (0.66); for the maximum balanced classification rate (BCR) criterion, RFC showed the highest BCR (0.68), and NBC showed the second highest (0.66) among the various ML algorithms for predicting uric acid status. In a comparison to the performance of NBC (area under the curve (AUC) = 0.669, 95% confidence intervals (CI) = 0.669⁻0.675) and RFC (AUC = 0.775, 95% CI 0.770⁻0.780) with a CLR algorithm (AUC = 0.568, 95% CI = 0.563⁻0.571), NBC and RFC showed significantly better performance ( p < 0.001).

CONCLUSIONS: The ML model was superior to the CLR model for the prediction of hyperuricemia. Future studies are needed to determine the best-performing ML algorithms based on data set characteristics. We believe that this study will be informative for studies using ML tools in clinical research.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app